Phathom Pharmaceuticals (PHAT)'s 30-day implied volatility (IV30) was 74.5% at the close on November 6, 2026, up from 70.6% the day before, against a 52-week range of 37.2% to 123.4%. Its 20-day historical volatility was 79.9%.
Data as of November 6, 2026.